COMMUNIQUÉS West-GlobeNewswire

Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
04/10/2019
NEW YORK, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of patients with rare neurological diseases, [...]
Cynata Advances Toward Phase 2 Clinical Trial of Cymerus(TM) MSCs in Patients with Osteoarthritis
04/10/2019
MELBOURNE, Australia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to provide an update on start-up [...]
Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
04/10/2019
SOUTH EASTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based [...]
Optinose Appoints Michael Richardson to New Position of Vice President, Business Development
04/10/2019
YARDLEY, Pa., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported the creation of a new [...]
Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting
04/10/2019
Faster Progressing Patients Who Received Reldesemtiv in the Trial Demonstrated Statistically Significant Differences in the Decline in ALSFRS-R Total Score SOUTH SAN FRANCISCO, Calif., Oct. 04, 2019 (GLOBE NEWSWIRE) -- [...]
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Begins Shipping Branded Cannabis Product to British Columbia Provincial Wholesaler
04/10/2019
VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced its 50%-owned joint venture for large-scale, low-cost, high-quality [...]
United Health Products Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the HemoStyp® Device for Use in Surgical Procedures
04/10/2019
HENDERSON, Nev., Oct. 04, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC) today announced that it has submitted a Premarket Approval (PMA) application for Class III approval to the FDA for [...]
Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
04/10/2019
Data presented in an oral presentation at World Muscle Society meeting highlighted safety, tolerability, pharmacokinetics and target engagement of losmapimod in patients with facioscapulohumeral dystrophy. CAMBRIDGE, [...]
Chi-Med Initiates an International Phase I/Ib Trial of HMPL-523 in Patients with Advanced Relapsed or Refractory Lymphoma
04/10/2019
LONDON, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) has initiated an international Phase I/Ib study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor [...]
Statement re: Appointment of Corporate Broker
04/10/2019
DXS INTERNATIONAL PLC Appointment of Corporate Broker The Board of DXS International plc (“the Company”), the NEX Growth Market quoted healthcare information and digital clinical decision support systems provider, is [...]
Press news Biocartis Group NV: Disclosure of a transparency notification
04/10/2019
PRESS RELEASE : REGULATED INFORMATION 4 October 2019, 7:00 CEST Disclosure of a transparency notification Mechelen, Belgium, 4 October 2019 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular [...]
NOTICE TO DISREGARD – Dabir Surfaces
04/10/2019
CHICAGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- We are advised by Dabir Surfaces that journalists and other readers should disregard the news release, “Dabir Surfaces Inc. Announces Master Product Agreement with Trinity [...]
Noushin Khoiny
04/10/2019
Dr. Noushin Khoiny discusses new California laws and how they will impact primary health care provider prescribing practices Long Beach, California, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Dr. Noushin Khoiny gave a talk on [...]
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters
04/10/2019
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) today announced that it has filed its notice of meeting and [...]
WW Announces Prepayment of Portion of Term Loan Facility
03/10/2019
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- On October 3, 2019, WW International, Inc. (NASDAQ: WW) announced that it intends to voluntarily prepay $50 million in aggregate principal amount of term loans outstanding [...]
Arbutus Announces Decision to Discontinue Development of AB-506, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B
03/10/2019
WARMINSTER, Pa., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced its decision to discontinue the clinical [...]
Aptevo Therapeutics Provides Corporate and Pipeline Update
03/10/2019
Reports Record Quarterly IXINITY ® Net Revenue and New Patient Conversions Following Launch of New 3,000 IU Assay Provides Update on Ongoing APVO436 Phase 1/1b Clinical Study; Evidence of Potential Clinical Activity [...]
Entasis Therapeutics Announces Multiple Presentations at ID Week 2019
03/10/2019
CEO Dr. Manos Perros participated in Industry Panel today WALTHAM, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel [...]
Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
03/10/2019
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of patients with rare neurological diseases, [...]

Pages